Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — August 2022

Genmab — August 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #952

    Blenrep har stærke data og er godkendt i både eu og us i 5. Linje. Men der er dette her øjen-problem…

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #953

      Link Preview Image
      See Boxed Warning | Side Effects | BLENREP (belantamab mafodotin-blmf)

      Review side effects for BLENREP (belantamab mafodotin-blmf), which is only available through the REMS program. See PI including Boxed Warning and Medication Guide for patients. For US residents only.

      favicon

      (www.blenrep.com)

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #954

        TRIMM - 3 https://clinicaltrials.gov/ct2/show/NCT05338775?term=Trimm+2&draw=2&rank=2

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #955

          Troede kun der var et TRIMM -2. ??

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #956

            Spændende at man igen forsøge sig med checkpoint inhibitorer i MM

            1 Reply Last reply
            0
            • D Offline
              D Offline
              deleted-user
              wrote on sidst redigeret af
              #957

              God eftermiddag. Selvom Genmab og JNJ ligger og slås en smule i den dumme voldgift, så fornemmer man, at samarbejdet de kommende mange år vil definere MM markedet med Dara, Tec, Tal og måske super-dara i spil

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #958

                Mon PD-1 inhibitoren er Cetrelimab? https://www.jnj.com/janssen-presents-results-from-phase-1b-2-norse-study-in-patients-with-metastatic-or-locally-advanced-urothelial-carcinoma-treated-with-balversa-erdafitinib-in-combination-with-cetrelimab-a-pd-1-inhibitor

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #959

                  Lidt flere spørgsmål til Q&A er mere end velkommen. 🙂

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bibob
                    wrote on sidst redigeret af
                    #960

                    Bulder 14.17. Det ville nok være nærliggende at tro. Da det er et in House drug.

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #961

                      Godmorgen. 🙂

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #962

                        Godmorgen. 🙂

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #963

                          Asian Markets Tumble Amid Global Sell-off https://www.proinvestor.com/investornyt/872173/asian-markets-tumble-amid-global-sell-off

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Stroka
                            wrote on sidst redigeret af
                            #964

                            God morgen. 🙂

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #965

                              Asien: Udsigt til strammere pengepolitik i USA og EU sender aktier ned https://www.proinvestor.com/investornyt/872177/asien-udsigt-til-strammere-pengepolitik-i-usa-og-eu-sender-aktier-ned

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #966

                                Aktier efter Jackson Hole: Intet nyt var skidt nyt https://www.proinvestor.com/boards/105698

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #967

                                  Aktier/åbning: Rød dyne over C25 efter Powell-tale
                                  https://www.proinvestor.com/investornyt/872209/aktier-abning-rod-dyne-over-c25-efter-powell-tale

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    BSinvest
                                    wrote on sidst redigeret af
                                    #968

                                    Hej Helge, Er der der plads til flere spørgsmål til Q&A?

                                    1 Reply Last reply
                                    0
                                    • D Offline
                                      D Offline
                                      deleted-user
                                      wrote on sidst redigeret af
                                      #969

                                      Der skulle være åbent for spg indtil kl. 12.... jo før jo bedre, så Helge ikke får stress 🙂

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #970

                                        GEN1053 starts recruiting https://www.clinicaltrials.gov/ct2/history/NCT05435339?A=2&B=3&C=merged#StudyPageTop

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #971

                                          not sure if this one was posted yet - Final Analysis of Phase 2 GRIFFIN Shows Daratumumab Improves PFS After 4 Years https://www.ajmc.com/view/final-analysis-of-phase-2-griffin-shows-daratumumab-improves-pfs-after-4-years

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper